Impact of %6 HES 130/0.4 and %4 Gelofusine Infusion on Kidney Function in the Living-donor Liver Transplantation

NCT02079350 · clinicaltrials.gov ↗

COMPLETED

Status

36

Enrollment

OTHER_GOV

Sponsor class

Conditions

Patients Undergoing Liver Transplantation

Interventions

DRUG: %6 HES and %4 Gelofusine

Sponsor

Turkiye Yuksek Ihtisas Education and Research Hospital